Actively Recruiting
Evaluating Bergen Four-Day Treatment for Obsessive-Compulsive Disorder in Finnish Psychiatric Care at Tampere University Hospital
Led by Tampere University Hospital · Updated on 2026-09-08
65
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the Bergen Four-Day Treatment B4DT for patients with obsessive-compulsive disorder OCD at Tampere University Hospital in Finland. The study aims to expand access to B4DT within the Finnish healthcare system, understand how well the model adapts, assess healthcare professionals attitudes, and evaluate treatment outcomes. Approximately 35 patients with significant OCD symptoms will participate, alongside about 30 psychiatric staff involved in patient referral and treatment. The treatment begins with a pre-assessment to evaluate patients motivation and readiness for exposure-based therapy. Participants then undergo a four-day intensive group treatment focused on exposure and response prevention. Following this, there is a three-month period of independent practice with a few therapist appointments. Healthcare professionals views on the intervention are also examined during the study. Participants will be assessed using various scales and questionnaires from before treatment through approximately four to six months of follow-up. These include measures of OCD symptoms, anxiety, depression, daily functioning, well-being, and treatment satisfaction. Self-reports from healthcare professionals will also be collected. The study monitors changes in symptoms and the impact of treatment, with participation lasting several months to cover treatment and follow-up.
CONDITIONS
Brief Title
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive Disorder
Research Team
A
Aino Mattila
P
Petra Sainio
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here